Back to Journals » Clinical Ophthalmology » Volume 15

Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections

Authors Antaki F, Milad D, Dirani A

Received 24 January 2021

Accepted for publication 3 March 2021

Published 12 March 2021 Volume 2021:15 Pages 1129—1131

DOI https://doi.org/10.2147/OPTH.S303551

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Scott Fraser


Fares Antaki,1,2 Daniel Milad,3 Ali Dirani4

1Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada; 2Centre Universitaire d’Ophtalmologie (CUO), Hôpital Maisonneuve-Rosemont, CIUSSS de l’Est-De-l’île-De-Montréal, Montreal, QC, Canada; 3Faculty of Medicine, Université Laval, Quebec City, QC, Canada; 4Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, Canada

Correspondence: Ali Dirani
Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec - Université Laval, Quebec City, QC, Canada
Email [email protected]

Abstract: Patients receiving regular anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections for neovascular age-related macular degeneration (nAMD) routinely undergo dilated fundus examination (DFE) at each visit. In this paper, we review the current evidence on the utility of DFE in guiding treatment of established patients with nAMD and discuss novel treatment algorithms that defer DFE assessments with the advent of optical coherence tomography (OCT). We also debate on the value of DFE in the current sanitary context of COVID-19 and highlight important clinical scenarios where it must be performed.

Keywords: age-related macular degeneration, dilated fundus exam, intravitreal injections, COVID-19, optical coherence tomography

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]